Editorial comment: A new direction in the treatment of male erectile dysfunction is to develop gene therapeutic interventions for restoring erectile potency. The rationale inherent in this application is that the scienti®c basis for penile erection uniquely affords an optimal situation for this sort of therapy. Precisely, the smooth muscle cell composition of the erectile tissue containing gap junctions for the intercellular transport of physiologically relevant ions and second messenger molecules implies that only a small portion of the corporal smooth cells requires genetic modi®cation to predispose the erectile tissue to react globally to an erectile stimulus. In addition, the fact that a minimal alteration in the physiologic equilibrium between contractile and relaxant effects in corporal smooth muscle is all that is necessary to elicit a profound effect on erectile function clinically invites discretely delivered local therapies. These investigators have selected as their molecular target the Ca 2 -sensitive K channel (maxi-K ), which serves as a major mechanistic factor for regulating the transcellular membrane potential that favors corporal tissue relaxation fundamental to the erectile process. The transfection of the maxi-K channel via naked pcDNA/hSlo cDNA, which encodes the channel, into 10 week old rat corporal smooth muscle in vivo signi®cantly augmented measurable erectile responses to electrical stimulation of the cavernous nerve compared with age-matched control animals, similar to responses obtained in young adult rats. These responses were sustained as long as two months following gene transfer and correlated with increased expression of the hSlo mRNA. On the basis of these results, it was reasoned that the increased expression of the maxi-K channel heightens the sensitivity of the corporal smooth muscle cells to a constant level of neural stimulation. The study is very exciting since it provides strong support for the potential utility of gene therapy in the clinical treatment of erectile dysfunction. The obvious implication is that the corporal smooth muscle incorporation of chromosomal material that primes erectile tissue responses in humans longterm would represent a signi®cant advance in treatment, if not`cure' conceivably, for diseased erectile tissue.
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